| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
| 01/02/2008 | CN101095712A The extracting of chrysanthemum rice extracts and the method for making the preparations thereof |
| 01/02/2008 | CN101095711A The extracting of chrysanthemum rice extracts and the method for making the preparations thereof |
| 01/02/2008 | CN101095707A Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating acute respiratory distress syndrome |
| 01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
| 01/02/2008 | CN101095673A Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone as the cytoplasm vacuolated medicine generated by restraining chloro-quinine inducement |
| 01/02/2008 | CN101095462A Method for synthesizing the feed additive - isoflavone |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358911C N-acetylglucosamine derivatives and use thereof |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358890C 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
| 01/02/2008 | CN100358874C 3,4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same |
| 01/02/2008 | CN100358872C The derivatives of pyridone and use thereof |
| 01/02/2008 | CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358529C Treatment of hyperproliferative disorders |
| 01/02/2008 | CN100358527C Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 01/02/2008 | CN100358512C Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
| 01/02/2008 | CN100358496C 'Xingnaojing' dripping pills for treating cephalitis and hepatic coma and preparation process thereof |
| 01/02/2008 | CN100358449C Odor free shoe pads and its production method |
| 01/02/2008 | CN100358426C Method for preparing soymilk powder contg. micron ginseng, tortoise, pearl, pollen for tonifying-Yin, dispelling-fatigue and enriching calcium |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314926 Inhibiting cell proliferation, breast cancer, prostate cancer, cervical cancer, lung cancer, or tumor cells |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314922 Cutaneous T-cell lymphoma associated genes; expression in malignant tumors and in ordinary testis tissue, diagnosis and therapy of tumoral diseases |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
| 01/01/2008 | US7314877 Benzofuran derivative |
| 01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension |
| 01/01/2008 | US7314865 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314642 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 01/01/2008 | US7314499 Method and device for manufacturing advanced water containing ultra-fine gold particles |
| 12/27/2007 | WO2007149797A2 Use of organic compounds |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |
| 12/27/2007 | WO2007149000A2 New structural protein preparations |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148835A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 12/27/2007 | WO2007148739A1 Cell activator, anti-aging agent and extracellular matrix production promoter derived from plant |
| 12/27/2007 | WO2007148737A1 Method of preparing plant extract, plant extract and use of the same |
| 12/27/2007 | WO2007148714A1 Implant using rifamycin derivative |
| 12/27/2007 | WO2007148713A1 Drug for treating vascular disease or drug for controlling cell proliferation comprising rifamycin derivative as the active ingredient |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148631A1 Composition for promoting the production of equol |
| 12/27/2007 | WO2007148474A1 Preparation for external application to skin containing triterpenic acid |
| 12/27/2007 | WO2007147590A2 Solution and method to reduce, treat and/or prevent oxidative stress and cell activation |
| 12/27/2007 | US20070300327 Plant enzymes for bioconversion |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299136 Crystalline and Amorphous Forms of Efaproxiral Sodium |
| 12/27/2007 | US20070299127 Compositions and kits comprising a melatonin component and an omega-3-fatty acid component |
| 12/27/2007 | US20070299125 Substituted indoles |
| 12/27/2007 | US20070299121 administering sublingually to a horse a semisolid transmucosal gel containing detomidine, hydroxypropyl cellulose, sodium lauryl sulfate, propylene glycol and water for providing sedation and analgesia; rapid onset of action, low irritation potential in the oral mucosa |
| 12/27/2007 | US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders |
| 12/27/2007 | US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/27/2007 | US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| 12/27/2007 | US20070299088 Novel Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers |
| 12/27/2007 | US20070299059 Compostions and methods relating to novel compounds and targets thereof |
| 12/27/2007 | US20070299055 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 12/27/2007 | US20070299052 Inhibitors of IAP |
| 12/27/2007 | US20070299048 Combination of Gaboxadol and 5Ht2 Antagonists |
| 12/27/2007 | US20070299047 Combination of Organic Compounds |
| 12/27/2007 | US20070299042 Use of etodolac to treat hyperplasia |
| 12/27/2007 | US20070299040 Composition for Preventing a Cold |
| 12/27/2007 | US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 12/27/2007 | US20070299031 Therapeutic agent for tumor of neural origin |
| 12/27/2007 | US20070299030 MicroRNA biomarkers for human breast and lung cancer |
| 12/27/2007 | US20070299021 Modified Tailed Oligonucleotides |
| 12/27/2007 | US20070299016 Specific Antibodies for Diagnosing Heart Failure |
| 12/27/2007 | US20070299015 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 12/27/2007 | US20070299014 Casein hydrolyzate, process for producing the same and use thereof |
| 12/27/2007 | US20070299011 Appoptosin and uses thereof for treating neurodegenerative disease and cancer |
| 12/27/2007 | US20070299008 Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells |
| 12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
| 12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
| 12/27/2007 | US20070298133 Compositions and kits comprising a melatonin component and a flavanol component |
| 12/27/2007 | US20070298120 Photoreactive Compound Specifically Binding to Calcium Binding Proteins |
| 12/27/2007 | US20070298117 Compositions and kits comprising a melatonin component and a chondroprotective component |
| 12/27/2007 | US20070298116 Amorphous, spray-dried powders having a reduced moisture content and a high long term stability |
| 12/27/2007 | US20070298115 Nanoparticulate fibrate formulations |
| 12/27/2007 | US20070298104 Cyanoisoquinoline compounds and methods of use thereof |
| 12/27/2007 | US20070298084 Flat System for Using in the Oral Cavity |
| 12/27/2007 | US20070298081 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs |
| 12/27/2007 | US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |